Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


PM Pham Minh Chinh reviews past term, outlines expectations for new tenure

Hanoi, April 5 -- Prime Minister Pham Minh Chinh has written an article reviewing the 2021-2026 term and outlining expectations for the new tenure. The Vietnam News Agency (VNA) respectfully introduce... Read More


Prime Minister Pham Minh Chinh reviews past term, outlines expectations for new tenure

Hanoi, April 5 -- Prime Minister Pham Minh Chinh has written an article reviewing the 2021-2026 term and outlining expectations for the new tenure. The Vietnam News Agency (VNA) respectfully introduce... Read More


Pakistani journalists boycott National Assembly over layoffs, unpaid salaries

India, April 5 -- Pakistani journalists staged a walkout from the press gallery of the National Assembly in Islamabad on Tuesday, boycotting coverage of parliamentary proceedings to protest recent lay... Read More


A tricky social media polarisation is emerging in Nepal. How will the government handle it?

Nepal, April 5 -- When the KP Sharma Oli government cracked down on social media platforms last year, it triggered a massive uprising that eventually toppled his government and displaced the old guard... Read More


Why We Celebrate This Way: History Behind Popular Easter Traditions - Know About the Traditions Here

India, April 5 -- Hunting for eggs on the lawn, enjoying jelly beans, and arguing over who gets the biggest chocolate bunny-these are familiar Easter moments for many people. But these traditions are ... Read More


Rashmika Mandanna's 30th birthday: From film earnings to properties and cars, check out her net worth of Rs.66 crore

New Delhi, April 5 -- Actor Rashmika Mandanna turned 30. The popular pan-India star who is known across Telugu, Kannada, Hindi, and Tamil cinema is celebrating her first birthday as actor Vijay Devera... Read More